5
Clinical Trials associated with Recombinant human keratinocyte growth factor-2(Shanghai Newsummit Biopharma)评价冻干重组人角质细胞生长因子-2外用治疗皮肤局部浅II度灼伤创面的安全性和有效性II期临床试验
[Translation] Phase II clinical trial to evaluate the safety and efficacy of freeze-dried recombinant human keratinocyte growth factor-2 for topical treatment of superficial second-degree burns on the skin
评价冻干重组人角质细胞生长因子-2治疗皮肤局部浅Ⅱ度灼伤创面的临床安全性和有效性,探索有效治疗剂量,为Ⅲ期临床提供科学试验依据.
[Translation] To evaluate the clinical safety and efficacy of freeze-dried recombinant human keratinocyte growth factor-2 in the treatment of superficial second-degree burns on the skin, explore the effective therapeutic dose, and provide scientific experimental basis for phase III clinical trials.
评价冻干重组人角质细胞生长因子-2外用治疗皮肤局部II度灼伤创面的药代动力学及安全性和有效性II期临床试验
[Translation] Phase II clinical trial to evaluate the pharmacokinetics, safety and efficacy of freeze-dried recombinant human keratinocyte growth factor-2 for topical treatment of second-degree burns on the skin
评价冻干重组人角质细胞生长因子-2外用治疗皮肤治疗皮肤局部Ⅱ度灼伤创面的安全耐受性和药代动力学试验(两中心、开放、多剂量、创面吸收)
[Translation] Evaluation of the safety, tolerability and pharmacokinetics of freeze-dried recombinant human keratinocyte growth factor-2 for topical treatment of skin partial second-degree burns (two-center, open, multiple doses, wound absorption)
冻干重组人角质细胞生长因子(rhKGF-2)I期临床试验(安全耐受性研究)
[Translation] Phase I clinical trial of freeze-dried recombinant human keratinocyte growth factor (rhKGF-2) (safety and tolerance study)
观察rhKGF-2在中国健康受试者皮肤局部应用的安全性和耐受程度;
[Translation] To observe the safety and tolerability of topical application of rhKGF-2 to the skin of healthy Chinese subjects;
100 Clinical Results associated with Recombinant human keratinocyte growth factor-2(Shanghai Newsummit Biopharma)
100 Translational Medicine associated with Recombinant human keratinocyte growth factor-2(Shanghai Newsummit Biopharma)
100 Patents (Medical) associated with Recombinant human keratinocyte growth factor-2(Shanghai Newsummit Biopharma)
100 Deals associated with Recombinant human keratinocyte growth factor-2(Shanghai Newsummit Biopharma)